Authors
No takes yet. Share an insight, caveat, or question.
This patent reports the preparation of novel nlrp3 inflammasome inhibitors, highlighting their pharmaceutical applications in immune responses.
Zhou et al. (2025) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: